Health Condition 1: B354- Tinea corporis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients Diagnosed With Tinea Corporis 2. Patients With Mild To Moderate case of Tinea Corporis 3. Parents Submit Written Consent To Participate In The Study
Exclusion criteria
Exclusion criteria: 1. Patients With Hemorrhagic Pustular And Vesicular Rashes 2. Patients Who Refuse For Investigations On Follow Up Were Dropped From The Study 3. Patients With Any Acute Systemic Illness 4. Patient That Are Using Systemic Steroids 5. Patients Suffering From Any Life Threatening Conditions 6. Patients Showing Signs Of Intolerance To The Formulation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Complete resolution of all signs and symptoms of Tinea corporis (erythema, scaling, itching, vesiculation) with no visible lesion 2. Negative potassium hydroxide (KOH) microscopy AND negative fungal culture from lesion scrapings.Timepoint: Baseline (Day 0), 2nd Week, 4th Week And 6th Week | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient satisfaction and improving quality of life 2. To establish the safety and efficacy of the study product 3. No recurrence of symptoms after cessation of therapyTimepoint: Baseline (Day 0) and End of Study (6th Week) | — |
Countries
India
Contacts
Institute Of Medical Sciences Banaras Hindu University